Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients

Understanding antibody-based SARS-CoV-2 immunity in hematologic malignancy (HM) patients following infection is crucial to inform vaccination strategies for this highly vulnerable population. This cross-sectional study documents the anti-SARS-CoV-2 humoral response and serum neutralizing activity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgogna, Cinzia, Bruna, Riccardo, Griffante, Gloria, Martuscelli, Licia, De Andrea, Marco, Ferrante, Daniela, Patriarca, Andrea, Mahmoud, Abdurraouf Mokhtar, Gaidano, Valentina, Marchetti, Monia, Rapezzi, Davide, Lai, Michele, Pistello, Mauro, Ladetto, Marco, Massaia, Massimo, Gaidano, Gianluca, Gariglio, Marisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764505/
https://www.ncbi.nlm.nih.gov/pubmed/35042847
http://dx.doi.org/10.1038/s41408-022-00608-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764505/
https://www.ncbi.nlm.nih.gov/pubmed/35042847
http://dx.doi.org/10.1038/s41408-022-00608-6

Ejemplares similares